Dong-Chul Kim (Dong Chul Kim)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Lymph Node Metastasis

Systematic Review

Oxide Nanoparticles

Top Venues

Journal of personalized medicine

Disease markers

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Woorim Kim, Young-Ah Cho, Dong-Chul Kim, Kyung-Eun Lee
Elevated Risk of Fluoropyrimidine-Associated Toxicity in European Patients with DPYD Genetic Polymorphism: A Systematic Review and Meta-Analysis. Journal of personalized medicine 12 (2) (2022)
Woorim Kim, Young-Ah Cho, Dong-Chul Kim, Kyung-Eun Lee
Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Hyun Min Koh, Bo Gun Jang, Chang Lim Hyun, Dong-Chul Kim
Prognostic Value of NOX4 Expression in Cancer Patients: A Systematic Review and Meta-analysis. Disease markers 2022 (2022)
Hyun Min Koh, Hyun Ju Lee, Dong-Chul Kim
Usefulness of CD109 expression as a prognostic biomarker in patients with cancer: A systematic review and meta-analysis. Medicine 100 (11) (2021)
Hyun Min Koh, Dong-Chul Kim
Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis. Medicine 99 (32) (2020)